These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37495851)

  • 1. Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease.
    Matt RA; Martin RS; Evans AK; Gever JR; Vargas GA; Shamloo M; Ford AP
    Handb Exp Pharmacol; 2023 Jul; ():. PubMed ID: 37495851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system.
    Feinstein DL; Kalinin S; Braun D
    J Neurochem; 2016 Oct; 139 Suppl 2():154-178. PubMed ID: 26968403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study.
    Laurencin C; Lancelot S; Brosse S; Mérida I; Redouté J; Greusard E; Lamberet L; Liotier V; Le Bars D; Costes N; Thobois S; Boulinguez P; Ballanger B
    Brain; 2024 Apr; 147(4):1377-1388. PubMed ID: 37787503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of noradrenaline in cognition and cognitive disorders.
    Holland N; Robbins TW; Rowe JB
    Brain; 2021 Sep; 144(8):2243-2256. PubMed ID: 33725122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
    Srinivasan J; Schmidt WJ
    Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenaline in Alzheimer's Disease: A New Potential Therapeutic Target.
    Gutiérrez IL; Dello Russo C; Novellino F; Caso JR; García-Bueno B; Leza JC; Madrigal JLM
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
    Doppler CEJ; Kinnerup MB; Brune C; Farrher E; Betts M; Fedorova TD; Schaldemose JL; Knudsen K; Ismail R; Seger AD; Hansen AK; Stær K; Fink GR; Brooks DJ; Nahimi A; Borghammer P; Sommerauer M
    Brain; 2021 Oct; 144(9):2732-2744. PubMed ID: 34196700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases.
    Betts MJ; Kirilina E; Otaduy MCG; Ivanov D; Acosta-Cabronero J; Callaghan MF; Lambert C; Cardenas-Blanco A; Pine K; Passamonti L; Loane C; Keuken MC; Trujillo P; Lüsebrink F; Mattern H; Liu KY; Priovoulos N; Fliessbach K; Dahl MJ; Maaß A; Madelung CF; Meder D; Ehrenberg AJ; Speck O; Weiskopf N; Dolan R; Inglis B; Tosun D; Morawski M; Zucca FA; Siebner HR; Mather M; Uludag K; Heinsen H; Poser BA; Howard R; Zecca L; Rowe JB; Grinberg LT; Jacobs HIL; Düzel E; Hämmerer D
    Brain; 2019 Sep; 142(9):2558-2571. PubMed ID: 31327002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic pathways of locus coeruleus in Parkinson's and Alzheimer's pathology.
    Singh S
    Int J Neurosci; 2020 Mar; 130(3):251-261. PubMed ID: 31575316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α
    Horrillo I; Ortega JE; Diez-Alarcia R; Urigüen L; Meana JJ
    Neuropharmacology; 2019 Nov; 158():107731. PubMed ID: 31376424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenaline release in the locus coeruleus modulates memory formation and consolidation; roles for α- and β-adrenergic receptors.
    Gibbs ME; Hutchinson DS; Summers RJ
    Neuroscience; 2010 Nov; 170(4):1209-22. PubMed ID: 20709158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid and positron-emission tomography biomarkers for noradrenergic dysfunction in neurodegenerative diseases: a systematic review and meta-analysis.
    Lancini E; Haag L; Bartl F; Rühling M; Ashton NJ; Zetterberg H; Düzel E; Hämmerer D; Betts MJ
    Brain Commun; 2023; 5(3):fcad085. PubMed ID: 37151227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Vulnerability of the Locus Coeruleus Noradrenergic System and its Role in Modulation of Neuroinflammation, Cognition, and Neurodegeneration.
    Evans AK; Defensor E; Shamloo M
    Front Pharmacol; 2022; 13():1030609. PubMed ID: 36532725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic receptor antagonism is proinflammatory and exacerbates neuroinflammation in a mouse model of Alzheimer's Disease.
    Evans AK; Ardestani PM; Yi B; Park HH; Lam RK; Shamloo M
    Neurobiol Dis; 2020 Dec; 146():105089. PubMed ID: 32971233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition.
    Coull JT
    Drugs Aging; 1994 Aug; 5(2):116-26. PubMed ID: 7981483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing effects of β-2 and β-1 adrenergic receptor signaling on neuroinflammation and dopaminergic neuron survival in α-synuclein-mediated neurotoxicity.
    Torrente D; Su EJ; Schielke GP; Warnock M; Mann K; Lawrence DA
    J Neuroinflammation; 2023 Mar; 20(1):56. PubMed ID: 36864439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical effect of noradrenaline-mediated neurotransmission in the antinociceptive phenomenon that accompanies tonic-clonic seizures: role of locus coeruleus neurons and α(2)- and β-noradrenergic receptors.
    Felippotti TT; dos Reis Ferreira CM; de Freitas RL; de Oliveira RC; de Oliveira R; Paschoalin-Maurin T; Coimbra NC
    Epilepsy Behav; 2011 Oct; 22(2):165-77. PubMed ID: 21813330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects: implications for Parkinson's disease.
    O'Neill E; Harkin A
    Neural Regen Res; 2018 Aug; 13(8):1332-1337. PubMed ID: 30106035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenergic mechanisms in neurodegenerative diseases: a theory.
    Marien MR; Colpaert FC; Rosenquist AC
    Brain Res Brain Res Rev; 2004 Apr; 45(1):38-78. PubMed ID: 15063099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased noradrenergic neurotransmission to a pain facilitatory area of the brain is implicated in facilitation of chronic pain.
    Martins I; Carvalho P; de Vries MG; Teixeira-Pinto A; Wilson SP; Westerink BH; Tavares I
    Anesthesiology; 2015 Sep; 123(3):642-53. PubMed ID: 26146901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.